Blog - Page 2897 of 5594

MondayJul 01, 2013 1:20 pm

Award-Winning Mobile Design Director Recruited by Virtual Piggy, Inc. (VPIG)

Virtual Piggy, innovator in safe youth payments, announced today the appointment of Ivo Weevers to Creative Director of Mobile Design. He will oversee and lead the mobile consumer experience team. An accomplished design leader, Weevers brings 15 years of experience in creating highly successful device, mobile, web, and other desktop products across multiple platforms. With a strong background in directing design work and leading international design teams in a variety of industries, some of which include social media, telecom, device, banking, travel, entertainment, and medical. Most recently Weevers headed up the design team for the Ubuntu operating system, where he…

MondayJul 01, 2013 1:15 pm

QualityStocks Production Team Captures Significance of Rafarma Pharmaceuticals, Inc. (RAFA) World Class Production Facility

Rafarma Pharmaceuticals has made a significant investment in a 270,000-square-foot state-of-the-art production facility in the economic development zone in Terbuny, Lipetsk Region, south of Moscow. This sprawling, multi-profile pharmaceutical plant has the capability and space to produce all types and forms of medical drugs of various pharmacological groups. The facility was designed to accommodate a fair share of the burgeoning Russian pharmaceutical market, which is growing in tremendous leaps and bounds following an aggressive development campaign launched by the Russian government in 2010. Upon full production, which is expected to commence later this year, Rafarma anticipates being one of the…

MondayJul 01, 2013 12:23 pm

Oxygen Biotherapeutics, Inc. (OXBT) Enrolls First patients in Phase IIb Clinical Trial of Oxycyte

Oxygen Biotherapeutics is a company developing medical products that efficiently deliver oxygen to body tissues. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier, Oxycyte, for intravenous delivery for indications such as traumatic brain injury, decompression sickness, and stroke. The company reported today the enrollment of the first patient in the second cohort of its global Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with severe, non-penetrating traumatic brain injury. The first patient was enrolled at Israel's Rambam Health Care Campus. This neurotrauma center treats approximately 200 severe brain injuries annually. The…

MondayJul 01, 2013 11:52 am

DoMark International, Inc. (DOMK) Poised to Benefit from Apple, Samsung Super Sales

DoMark International operates through wholly owned subsidiary SolaWerks to develop innovative consumer electronics products. SolaWerks’ business strategy is to acquire and develop energy-efficient technology with the potential to generate significant profit. The company designs its technology to work with Apple and Samsung devices, among others, and stands to benefit from the brands’ popularity. For the first quarter of 2013 Apple sold 37.4 million iPhones, an increase compared to iPhone sales of 35.1 million in the comparable quarter of 2012. Samsung’s flagship Galaxy smartphone sold more than 10 million units in less than a month, recording $23.6 billion in smartphone sales…

MondayJul 01, 2013 11:10 am

Raptor Resources Holdings Inc. (RRHI) Releases 2nd Edition of RaptorNews

Raptor Resources Holdings today posted the 2nd edition of RaptorNews, an online publication that provides the latest company news. This issue announces that the company is forging an alliance with Steinbock Minerals Ltd. and Yasheya Ltd. via a Memorandum of Understanding. The partnerships being pursued represent the missing link to Raptor Resources’ ability to establish a strong presence in the barite marketplace as an emerging high-quality source. Partnering with these two companies will surround Raptor Resources with established industry leaders in the worldwide distribution, marketing, sales, and delivery of industrial minerals. During the due diligence period, the companies will be…

MondayJul 01, 2013 9:25 am

Soligenix, Inc. (SNGX) Completes Phase 1 Study with SGX203, Treatment of Pediatric Crohn’s Disease

Soligenix, a clinical stage biopharmaceutical company developing products to treat serious gastrointestinal diseases, has enrolled and treated all 24 patients in the phase 1 Study BDP-PCD-01, the first clinical study for development of SGX203 (oral BDP) for the treatment of pediatric Crohn's disease. The objective of Study BDP-PCD-01 was to further characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profile of the company's proprietary oral BDP formulation. Soligenix reports that the data was complementary to results previously obtained and confirms the safety profile observed in all previous clinical studies with oral BDP. This study enrolled subjects between the ages of 18-22.…

MondayJul 01, 2013 9:14 am

Respect Your Universe, Inc. (RYUN) Announces James R. Nowodworski as CFO

Respect Your Universe announced that Mr. James R. Nowodworski has been appointed as its Chief Financial Officer, effective July 23, 2013. Mr. Nowodworski is replacing Aaron Loreth, who recently resigned as the company’s CFO. "We are lucky to have a seasoned business and financial professional of Jim's caliber join our team in a senior financial management position," noted Craig Brod, RYU’s Chief Executive Officer. "We look forward to Jim's active role in guiding the financial management of our company and our anticipated successful expansion in the retail sector. We are excited to have him on board." Mr. Nowodworski, a Certified…

MondayJul 01, 2013 8:38 am

Rainbow Coral Corp. (RBCC) Partner Successfully Raises Funds for New Drug Delivery Solutions

Today before the opening bell, Rainbow Coral applauded the fundraising results achieved by joint venture partner TheraKine, Ltd. “TheraKine has done a tremendous job of bringing in outside funds to help push its innovations further into a hungry marketplace,” said RBCC CEO Patrick Brown. “The interest in TheraKine’s new drug delivery solutions is a fantastic illustration of this new system’s incredible market potential.” Rainbow Coral signed a joint venture agreement with TheraKine earlier this year to help market and develop a revolutionary, sustained-release drug delivery platform designed to make local delivery of biologic agents and small molecules safer, more effective,…

FridayJun 28, 2013 3:43 pm

South American Gold Corp. (SAGD) Offers Operational Update and Corporate Project Overview for 2013 Activities

South American Gold has assembled a nice portfolio of gold and silver exploration interests, both at home here in the U.S. with their New Light Mine gold-silver project up in northern Washington State, the Baltimore Silver project in Montana, the newer Kelly Project group of mining claims in western Montana, and the GB-2 mining claims in Arizona, as well as abroad in Colombia via the Narino Department in the south and the Santacruz Gold project. Today the company was pleased to offer markets a sweeping update on their 2013 activities and developments. The company is hard at work vetting existing…

FridayJun 28, 2013 1:02 pm

The Guitammer Company (GTMM) – Technological Evolution in Motion

The Guitammer Company was founded by musician, composer, and producer Ken McCaw, who was looking for a way to commercialize a patented guitar accessory called the Hammer Jammer. The next product to emerge from Guitammer was the solution to a problem McCaw and his drummer were experiencing in wanting to be able to feel the low end without turning the stage monitors up so loud that it disturbed the rest of the band. This was the moment the idea for ButtKicker® brand low frequency audio transducers were born, offering monitoring, timing, and synchronization by allowing the musicians to feel the…

Site Search

Company Search